نوع مقاله : مروری
عنوان مقاله English
نویسندگان English
Abstract:
The advancement and exploitation of science have always been leveraged to enhance quality of life and overcome societal challenges. In recent years, with the increasing prevalence of diseases such as cancer, researchers have intensified their efforts to combat them. The emergence of nanotechnology as a pervasive science has brought significant potential to various fields, including health and medicine. The use of nanocarriers for the intelligent and targeted delivery of drugs or genes to specific sites has been among the extensive research conducted to combat diseases. Among these, polymer-based nanostructures have attracted researchers' attention due to their biocompatibility with the human body and the possibility of synthesizing and modifying structures as desired, distinguishing them from other drug/gene delivery nanostructures. Since the introduction of the CRISPR/Cas9 system in 2016 as a gene-editing tool employed in the treatment of lung cancer, research directions have shifted towards gene delivery based on gene editing. This paper provides a brief introduction to the distinctions between drug and gene delivery, compares various types of nanocarriers, and reviews cationic non-viral nanocarriers with a focus on the CRISPR/Cas9 gene-editing system.
کلیدواژهها English
Pillai G. Nanotechnology toward treating cancer: A comprehensive review. Applications of targeted nano drugs and delivery systems. 2019:221-56.
Kang YK, Kwon K, Ryu JS, Lee HN, Park C, Chung HJ. Nonviral genome editing based on a polymer-derivatized CRISPR nanocomplex for targeting bacterial pathogens and antibiotic resistance. Bioconjugate chemistry. 2017;28(4):957-67.
Li L, Hu S, Chen X. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities. Biomaterials. 2018;171:207-18.
Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, et al. CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduction and Targeted Therapy. 2023;8(1):1):36.
https://pubmed.nih.gov/, 2024.
Company TBR. CRISPR And Cas Gene Market Definition. wwwthebusinessresearchcompanycom. 2024.
سرکندی مک. مقدمهای بر رسانش هدفمند دارو، ژن و سلول. ماهنامه مهندسی پزشکی و تجهیزات آزمایشگاهی. ۱۳۹۶;۲۰۲.
Li L, He Z-Y, Wei X-W, Gao G-P, Wei Y-Q. Challenges in CRISPR/CAS9 delivery: potential roles of nonviral vectors. Human gene therapy. 2015;26(7):452-62.
Li L, Song L, Liu X, Yang X, Li X, He T, et al. Artificial virus delivers CRISPR-Cas9 system for genome editing of cells in mice. ACS nano. 2017;11(1):95-111.
Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, et al. Cellular uptake of nanoparticles: journey inside the cell. Chemical society reviews. 2017;46(14):4218-44.
Rajeev A, Siby A, Koottungal MJ, George J, John F. Knocking down barriers: advances in siRNA delivery. ChemistrySelect. 2021;6(46):13350-62.
Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nature reviews Drug discovery. 2009;8(2):129-38.
Samal SK, Dash M, Van Vlierberghe S, Kaplan DL, Chiellini V, Van Blitterswijk C, et al. Cationic polymers and their therapeutic potential. Chemical Society Reviews. 2012;41(21):7147-94.
Neurath AR, Strick N, Li Y-Y. Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides. BMC Infectious Diseases. 2002;2:1-11.
Putnam D. Polymers for gene delivery across length scales. Nature materials. 2006;5(6.439-51.
Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery. Advanced drug delivery reviews. 2010;62(1):83-99.
Zhan C, Meng Q, Li Q, Feng L, Zhu J, Lu W. Cyclic RGD–Polyethylene Glycol–Polyethylenimine for Intracranial Glioblastoma-Targeted Gene Delivery. Chemistry–An Asian Journal. 2012;7(1):91-6.
Sawant RR, Sriraman SK, Navarro G, Biswas S, Dalvi RA, Torchilin VP. Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery. Biomaterials. 2012;33(15):3942-51.
Liu S, Zhou D, Yang J, Zhou H, Chen J, Guo T. Bioreducible zinc (II)-coordinative polyethylenimine with low molecular weight for robust gene delivery of primary and stem cells. Journal of the American Chemical Society. 2017;139(14):5102-9.
Fatemi SM, Fatemi SJ, Abbasi Z. PAMAM dendrimer-based macromolecules and their potential applications: recent advances in theoretical studies. Polymer Bulletin. 2020;77(12):6671-91.
Haensler J, Szoka Jr FC. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate chemistry. 1993;4(5):372-9.
Li J, Liang H, Liu J, Wang Z. Poly (amidoamine)(PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. International journal of pharmaceutics. 2018;546(1-2):215-25.
Wang J, Hu X, Wang D, Xie C, Lu W, Song J, et al. 2-Aminoimidazole facilitates efficient gene delivery in a low molecular weight poly (amidoamine) dendrimer. Organic & Biomolecular Chemistry. 2018;16(24):4464-70.
Shukla R, Thomas TP, Peters J, Kotlyar A, Myc A, Baker Jr JR. Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates. Chemical communications. 2005(46):5739-41.
Cui S-h, Zhi D-f, Zhao Y-n, Chen H-y, Meng Y, Zhang C-m, et al. Cationic liposomes with folic acid as targeting ligand for gene delivery. Bioorganic & Medicinal Chemistry Letters. 2016;26(16):4025-9.
Liu C, Liu X, Rocchi P, Qu F, Iovanna JL, Peng L. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo. Bioconjugate chemistry. 2014;25(3):521-32.
Wen Y, Guo Z, Du Z, Fang R, Wu H, Zeng X, et al. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives. Biomaterials. 2012;33(32):8111-21.
Dehshahri A, Sadeghpour H. Surface decorations of poly (amidoamine) dendrimer by various pendant moieties for improved delivery of nucleic acid materials. Colloids and Surfaces B: Biointerfaces. 2015;132:85-102.
Yellepeddi VK, Kumar A, Palakurthi S. Surface modified poly (amido) amine dendrimers as diverse nanomolecules for biomedical applications. Expert opinion on drug delivery. 2009;6(8):835-50.
Yang J, Zhang Q, Chang H, Cheng Y. Surface-engineered dendrimers in gene delivery. Chemical reviews. 2015;115(11):5274-300.
Alsalhi MS, Royall PG, Chan KLA. Mechanistic study of the solubilization effect of basic amino acids on a poorly water-soluble drug. RSC advances. 2022;12(30):19040-53.
Wang M, Cheng Y. The effect of fluorination on the transfection efficacy of surface-engineered dendrimers. Biomaterials. 2014;35(24):6603-13.
Wang M, Liu H, Li L, Cheng Y. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios. Nature communications. 2014;5(1):3053.
Wang M, Cheng Y. Structure-activity relationships of fluorinated dendrimers in DNA and siRNA delivery. Acta Biomaterialia. 2016;46:204-10.
Wang F, Hu K, Cheng Y. Structure-activity relationship of dendrimers engineered with twenty common amino acids in gene delivery. Acta Biomaterialia. 2016;29:94-102.
He B, Wang Y, Shao N, Chang H, Cheng Y. Polymers modified with double-tailed fluorous compounds for efficient DNA and siRNA delivery. Acta biomaterialia. 2015;22:111-9.
Liu H, Wang Y, Wang M, Xiao J, Cheng Y. Fluorinated poly (propylenimine) dendrimers as gene vectors. Biomaterials. 2014;35(20):5407-13.
Wang H-X, Li M, Lee CM, Chakraborty S, Kim H-W, Bao G, et al. CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery. Chemical reviews. 2017;117(15):9874-906.
Adli M. The CRISPR tool kit for genome editing and beyond. Nature communications. 2018;9(1):1911.
Peng Y-Y, Diaz-Dussan D, Kumar P, Narain R. Tumor microenvironment-regulated redox responsive cationic galactose-based hyperbranched polymers for siRNA delivery. Bioconjugate Chemistry. 2018;30(2):405-12.
Zhang Z, Wan T, Chen Y, Chen Y, Sun H, Cao T, et al. Cationic polymer-mediated CRISPR/Cas9 plasmid delivery for genome editing. Macromolecular rapid communications. 2019;40(5):1800068.
Ledford H, Callaway E. Pioneers of CRISPR gene editing win chemistry Nobel. Nature. 2020;586(7829):346-7.
Han X, Liu Z, Jo MC, Zhang K, Li Y, Zeng Z, et al. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation. Science advances. 2015;1(7):e1500454.
Qin L, Han X, Liu Z, Ma Y, Zhang K. Crispr-cas9 delivery to hard-to-transfect cells via membrane deformation. Google Patents; 2018.
Mianné J, Nasri A, Van CN, Bourguignon C, Fieldès M, Ahmed E, et al. CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles. BMC biology. 2022;20:1-15.
Cheng W-J, Chen L-C, Ho H-O, Lin H-L, Sheu M-T. Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy. International Journal of Nanomedicine. 2018:7079-94.
Ryu N, Kim M-A, Park D, Lee B, Kim Y-R, Kim K-H, et al. Effective PEI-mediated delivery of CRISPR-Cas9 complex for targeted gene therapy. Nanomedicine: Nanotechnology, Biology and Medicine. 2018;14(7):2095-102.
Rahimi H, Zaboli KA, Thekkiniath J, Mousavi SH, Johari B, Hashemi MR, et al. BSA-PEI nanoparticle mediated efficient delivery of CRISPR/Cas9 into MDA-MB-231 Cells. Molecular Biotechnology. 2022;64(12):1376-87.
Hasanzadeh A, Radmanesh F, Hosseini ES, Hashemzadeh I, Kiani J, Nourizadeh H, et al. Highly photoluminescent nitrogen-and zinc-doped carbon dots for efficient delivery of CRISPR/Cas9 and mRNA. Bioconjugate Chemistry. 2021;32(8):1875-87.
Hashemzadeh I, Hasanzadeh A, Radmanesh F, Khodadadi Chegeni B, Hosseini ES, Kiani J, et al. Polyethylenimine-functionalized carbon dots for delivery of CRISPR/Cas9 complexes. ACS Applied Bio Materials. 2021;4(11):7979-92.
Men JL, Zhang YT, Pei YB, Li N, Xiang JH, Zhou HL. Development of a PEI-coated SWNTs Nanocarrier for efficient delivery of CRISPR/Cas9 in early embryos of Litopenaeus vannamei. Aquaculture. 2024;581:740424.
Ma K, Li W, Zhu G, Sun S, Chi H, Yin Y, et al. Functionalized PDA/DEX-PEI@HA nanoparticles combined with sleeping-beauty transposons for multistage targeted delivery of CRISPR/Cas9 gene. Biomedicine & Pharmacotherapy. 2021;142:112061.
Rui Y, Varanasi M, Mendes S, Yamagata HM, Wilson DR, Green JJ. Poly (beta-amino ester) nanoparticles enable nonviral delivery of CRISPR-Cas9 plasmids for gene knockout and gene deletion. Molecular Therapy-Nucleic Acids. 2020;20:661-72.
